Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 290

1.

Geographical Disparities in Screening and Cancer-Related Health Behaviour.

Goodwin BC, Rowe AK, Crawford-Williams F, Baade P, Chambers SK, Ralph N, Aitken JF.

Int J Environ Res Public Health. 2020 Feb 14;17(4). pii: E1246. doi: 10.3390/ijerph17041246.

2.

Timing of exercise for muscle strength and physical function in men initiating ADT for prostate cancer.

Newton RU, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA, Hayne D, Taaffe DR.

Prostate Cancer Prostatic Dis. 2020 Feb 4. doi: 10.1038/s41391-019-0200-z. [Epub ahead of print]

PMID:
32020032
3.

Contemporary consumer perspectives on prostate cancer survivorship: Fifty voices.

Dunn J, Ralph N, Green A, Frydenberg M, Chambers SK.

Psychooncology. 2020 Jan 15. doi: 10.1002/pon.5306. [Epub ahead of print]

PMID:
31944447
4.

Nurse-Led Supportive Care Intervention for Men With Advanced Prostate Cancer: Healthcare Professionals' Perspectives.

Ralph N, Chambers SK, Laurie K, Oliffe J, Lazenby M, Dunn J.

Oncol Nurs Forum. 2020 Jan 1;47(1):33-43. doi: 10.1188/20.ONF.33-43.

5.

Outcomes of a randomized controlled trial assessing a smartphone Application to reduce unmet needs among people diagnosed with CancEr (ACE).

Livingston PM, Heckel L, Orellana L, Ashley D, Ugalde A, Botti M, Pitson G, Woollett A, Chambers SK, Parente P, Chirgwin J, Mihalopoulos C, Lavelle B, Sutton J, Phipps-Nelson J, Krishnasamy M, Simons K, Heynsbergh N, Wickramasinghe N, White V.

Cancer Med. 2020 Jan;9(2):507-516. doi: 10.1002/cam4.2718. Epub 2019 Nov 25.

6.

Prostate cancer survivorship priorities for men and their partners: Delphi consensus from a nurse specialist cohort.

Ralph N, Green A, Sara S, McDonald S, Norris P, Terry V, Dunn JC, Chambers SK.

J Clin Nurs. 2020 Jan;29(1-2):265-273. doi: 10.1111/jocn.15096. Epub 2019 Nov 27.

PMID:
31713906
7.

Strategies for increasing participation in mail-out colorectal cancer screening programs: a systematic review and meta-analysis.

Goodwin BC, Ireland MJ, March S, Myers L, Crawford-Williams F, Chambers SK, Aitken JF, Dunn J.

Syst Rev. 2019 Nov 4;8(1):257. doi: 10.1186/s13643-019-1170-x.

8.

Ten-year quality of life outcomes in men with prostate cancer.

Ralph N, Ng SK, Zajdlewicz L, Lepore SJ, Heathcote P, Kneebone A, Dunn JC, Chambers SK.

Psychooncology. 2020 Feb;29(2):444-449. doi: 10.1002/pon.5255. Epub 2019 Nov 20. No abstract available.

PMID:
31680363
9.

A systematic review of the unmet supportive care needs of men on active surveillance for prostate cancer.

McIntosh M, Opozda MJ, Evans H, Finlay A, Galvão DA, Chambers SK, Short CE.

Psychooncology. 2019 Dec;28(12):2307-2322. doi: 10.1002/pon.5262. Epub 2019 Nov 6. Review.

PMID:
31663180
10.

A prospective study of psychological distress after prostate cancer surgery.

Occhipinti S, Zajdlewicz L, Coughlin GD, Yaxley JW, Dunglison N, Gardiner RA, Chambers SK.

Psychooncology. 2019 Dec;28(12):2389-2395. doi: 10.1002/pon.5263. Epub 2019 Nov 10.

PMID:
31659807
11.

Community-based men's health promotion programs: eight lessons learnt and their caveats.

Oliffe JL, Rossnagel E, Bottorff JL, Chambers SK, Caperchione C, Rice SM.

Health Promot Int. 2019 Oct 11. pii: daz101. doi: 10.1093/heapro/daz101. [Epub ahead of print]

PMID:
31603471
12.

Quality of life considerations in the treatment of metastatic hormone-sensitive prostate cancer.

Chambers SK, Frydenberg M, Dunn J.

Lancet Oncol. 2019 Nov;20(11):1469-1471. doi: 10.1016/S1470-2045(19)30628-X. Epub 2019 Sep 29. No abstract available.

PMID:
31578172
13.

'Feelings, and feelings, and feelings. Let me try thinking instead': Screening for distress and referral to psychosocial care for men with prostate cancer.

Dunn J, Chambers SK.

Eur J Cancer Care (Engl). 2019 Sep;28(5):e13163. doi: 10.1111/ecc.13163. Epub 2019 Sep 10. No abstract available.

PMID:
31506990
14.

Reporting of Resistance Training Dose, Adherence, and Tolerance in Exercise Oncology.

Fairman CM, Nilsen TS, Newton RU, Taaffe DR, Spry N, Joseph D, Chambers SK, Robinson ZP, Hart NH, Zourdos MC, Focht BC, Peddle-McIntyre CJ, Galvão DA.

Med Sci Sports Exerc. 2020 Feb;52(2):315-322. doi: 10.1249/MSS.0000000000002127.

PMID:
31436734
15.

Identifying the exercise-based support needs and exercise programme preferences among men with prostate cancer during active surveillance: A qualitative study.

McIntosh M, Opozda M, Galvão DA, Chambers SK, Short CE.

Eur J Oncol Nurs. 2019 Aug;41:135-142. doi: 10.1016/j.ejon.2019.06.006. Epub 2019 Jun 14.

PMID:
31358246
16.

Re-imagining Psycho-oncology.

Chambers SK, Dunn J.

Eur J Cancer Care (Engl). 2019 Jul;28(4):e13136. doi: 10.1111/ecc.13136. No abstract available.

PMID:
31318133
17.

Understanding rural caregivers' experiences of cancer care when accessing metropolitan cancer services: a qualitative study.

Ugalde A, Blaschke S, Boltong A, Schofield P, Aranda S, Phipps-Nelson J, Chambers SK, Krishnasamy M, Livingston PM.

BMJ Open. 2019 Jul 11;9(7):e028315. doi: 10.1136/bmjopen-2018-028315.

18.

Peer support for the maintenance of physical activity and health in cancer survivors: the PEER trial - a study protocol of a randomised controlled trial.

Adlard KN, Jenkins DG, Salisbury CE, Bolam KA, Gomersall SR, Aitken JF, Chambers SK, Dunn JC, Courneya KS, Skinner TL.

BMC Cancer. 2019 Jul 3;19(1):656. doi: 10.1186/s12885-019-5853-4.

19.

Measuring Masculinity in Men With Chronic Disease.

Occhipinti S, Laurie K, Hyde MK, Martin S, Oliffe J, Wittert G, Chambers SK.

Am J Mens Health. 2019 Jul-Aug;13(4):1557988319859706. doi: 10.1177/1557988319859706.

20.

"I'm not doing that." An in-depth examination of nonparticipation in mail-out bowel cancer screening programs.

Goodwin BC, March S, Crawford-Williams F, Chambers SK, Dunn J.

Transl Behav Med. 2019 Jun 22. pii: ibz096. doi: 10.1093/tbm/ibz096. [Epub ahead of print]

PMID:
31228202
21.

Geographic variations in stage at diagnosis and survival for colorectal cancer in Australia: A systematic review.

Crawford-Williams F, March S, Goodwin BC, Ireland MJ, Chambers SK, Aitken JF, Dunn J.

Eur J Cancer Care (Engl). 2019 May;28(3):e13072. doi: 10.1111/ecc.13072. Epub 2019 May 5.

PMID:
31056787
22.

Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.

Dasgupta P, Baade PD, Aitken JF, Ralph N, Chambers SK, Dunn J.

Front Oncol. 2019 Apr 8;9:238. doi: 10.3389/fonc.2019.00238. eCollection 2019.

23.

Physical activity counselling and referrals by general practitioners for prostate cancer survivors in Australia.

Barnes K, Ball L, Galvão DA, Newton RU, Chambers SK, Harrison C.

Aust J Prim Health. 2019 Apr;25(2):152-156. doi: 10.1071/PY18131.

PMID:
30955507
24.

Circulating miRNA Profiling of Women at High Risk for Ovarian Cancer.

Pandey R, Woo HH, Varghese F, Zhou M, Chambers SK.

Transl Oncol. 2019 May;12(5):714-725. doi: 10.1016/j.tranon.2019.01.006. Epub 2019 Mar 9.

25.

Health Literacy Among Canadian Men Experiencing Prostate Cancer.

Seaton CL, Oliffe JL, Rice SM, Bottorff JL, Johnson ST, Gordon SJ, Chambers SK.

Health Promot Pract. 2019 Feb 21:1524839919827576. doi: 10.1177/1524839919827576. [Epub ahead of print]

PMID:
30791725
26.

Identifying priorities for cancer caregiver interventions: protocol for a three-round modified Delphi study.

Blaschke SM, Lambert SD, Livingston PM, Aranda S, Boltong A, Schofield P, Chambers SK, Krishnasamy M, Ugalde A.

BMJ Open. 2019 Feb 13;9(2):e024725. doi: 10.1136/bmjopen-2018-024725.

27.

Psychosocial predictors of hope two years after diagnosis of colorectal cancer: Implications for nurse-led hope programmes.

Grealish L, Hyde MK, Legg M, Lazenby M, Aitken JF, Dunn J, Chambers SK.

Eur J Cancer Care (Engl). 2019 May;28(3):e13010. doi: 10.1111/ecc.13010. Epub 2019 Feb 10.

PMID:
30740814
28.

Five-year outcomes from a randomised controlled trial of a couples-based intervention for men with localised prostate cancer.

Chambers SK, Occhipinti S, Stiller A, Zajdlewicz L, Nielsen L, Wittman D, Oliffe JL, Ralph N, Dunn J.

Psychooncology. 2019 Apr;28(4):775-783. doi: 10.1002/pon.5019. Epub 2019 Feb 18.

PMID:
30716188
29.

Comparison of Reproductive Function in Female TgMISIIR-TAg Transgenic and Wildtype C57BL/6 Mice.

Hoyer PB, Rice PF, Howard CC, Koevary JW, Dominguez Cooks JP, Hutchens GV, Chambers SK, Craig ZR, Connolly DC, Barton JK.

Comp Med. 2019 Feb 1;69(1):16-21. doi: 10.30802/AALAS-CM-18-000008. Epub 2018 Dec 27.

30.
31.

Multilevel model with random effects for clustered survival data with multiple failure outcomes.

Tawiah R, Yau KKW, McLachlan GJ, Chambers SK, Ng SK.

Stat Med. 2019 Mar 15;38(6):1036-1055. doi: 10.1002/sim.8041. Epub 2018 Nov 25.

PMID:
30474216
32.

BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma.

Lin KK, Harrell MI, Oza AM, Oaknin A, Ray-Coquard I, Tinker AV, Helman E, Radke MR, Say C, Vo LT, Mann E, Isaacson JD, Maloney L, O'Malley DM, Chambers SK, Kaufmann SH, Scott CL, Konecny GE, Coleman RL, Sun JX, Giordano H, Brenton JD, Harding TC, McNeish IA, Swisher EM.

Cancer Discov. 2019 Feb;9(2):210-219. doi: 10.1158/2159-8290.CD-18-0715. Epub 2018 Nov 13.

33.

Exercise Mode Specificity for Preserving Spine and Hip Bone Mineral Density in Prostate Cancer Patients.

Newton RU, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA, Wall BA, Bolam KA, Taaffe DR.

Med Sci Sports Exerc. 2019 Apr;51(4):607-614. doi: 10.1249/MSS.0000000000001831.

PMID:
30395051
34.

Quality of life and psychological distress in cancer survivors: The role of psycho-social resources for resilience.

Harms CA, Cohen L, Pooley JA, Chambers SK, Galvão DA, Newton RU.

Psychooncology. 2019 Feb;28(2):271-277. doi: 10.1002/pon.4934. Epub 2018 Dec 4.

PMID:
30380589
35.

Human ALKBH3-induced m1A demethylation increases the CSF-1 mRNA stability in breast and ovarian cancer cells.

Woo HH, Chambers SK.

Biochim Biophys Acta Gene Regul Mech. 2019 Jan;1862(1):35-46. doi: 10.1016/j.bbagrm.2018.10.008. Epub 2018 Oct 17.

PMID:
30342176
36.

Phenotype of vigilin expressing breast cancer cells binding to the 69 nt 3'UTR element in CSF-1R mRNA.

Woo HH, Lee SC, Stoffer JB, Rush D, Chambers SK.

Transl Oncol. 2019 Jan;12(1):106-115. doi: 10.1016/j.tranon.2018.09.012. Epub 2018 Oct 3.

37.

Nutrition care guidelines for men with prostate cancer undergoing androgen deprivation therapy: do we have enough evidence?

Barnes KA, Ball LE, Galvão DA, Newton RU, Chambers SK.

Prostate Cancer Prostatic Dis. 2019 May;22(2):221-234. doi: 10.1038/s41391-018-0099-9. Epub 2018 Oct 2. Review.

PMID:
30279584
38.

Interventions for prostate cancer survivorship: A systematic review of reviews.

Crawford-Williams F, March S, Goodwin BC, Ralph N, Galvão DA, Newton RU, Chambers SK, Dunn J.

Psychooncology. 2018 Oct;27(10):2339-2348. doi: 10.1002/pon.4888.

PMID:
30255558
39.

Geographic Disparities in Previously Diagnosed Health Conditions in Colorectal Cancer Patients Are Largely Explained by Age and Area Level Disadvantage.

Goodwin BC, March S, Ireland MJ, Crawford-Williams F, Ng SK, Baade PD, Chambers SK, Aitken JF, Dunn J.

Front Oncol. 2018 Sep 11;8:372. doi: 10.3389/fonc.2018.00372. eCollection 2018.

40.

The validity of the Distress Thermometer in female partners of men with prostate cancer.

Hyde MK, Zajdlewicz L, Lazenby M, Dunn J, Laurie K, Lowe A, Chambers SK.

Eur J Cancer Care (Engl). 2019 Jan;28(1):e12924. doi: 10.1111/ecc.12924. Epub 2018 Sep 25.

PMID:
30252180
41.

Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.

Taaffe DR, Galvão DA, Spry N, Joseph D, Chambers SK, Gardiner RA, Hayne D, Cormie P, Shum DHK, Newton RU.

BJU Int. 2019 Feb;123(2):261-269. doi: 10.1111/bju.14505. Epub 2018 Sep 21.

42.

A prospective and population-based inquiry on the use and acceptability of peer support for women newly diagnosed with breast cancer.

Legg M, Hyde MK, Occhipinti S, Youl PH, Dunn J, Chambers SK.

Support Care Cancer. 2019 Feb;27(2):677-685. doi: 10.1007/s00520-018-4358-z. Epub 2018 Jul 28.

PMID:
30056530
43.

Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: 24-month outcomes from a randomised controlled study.

Coughlin GD, Yaxley JW, Chambers SK, Occhipinti S, Samaratunga H, Zajdlewicz L, Teloken P, Dunglison N, Williams S, Lavin MF, Gardiner RA.

Lancet Oncol. 2018 Aug;19(8):1051-1060. doi: 10.1016/S1470-2045(18)30357-7. Epub 2018 Jul 17.

PMID:
30017351
44.

Health literacy and the health status of men with prostate cancer.

Goodwin BC, March S, Zajdlewicz L, Osborne RH, Dunn J, Chambers SK.

Psychooncology. 2018 Oct;27(10):2374-2381. doi: 10.1002/pon.4834. Epub 2018 Jul 27.

PMID:
29959807
45.

Geographical Variations in the Clinical Management of Colorectal Cancer in Australia: A Systematic Review.

Crawford-Williams F, March S, Ireland MJ, Rowe A, Goodwin B, Hyde MK, Chambers SK, Aitken JF, Dunn J.

Front Oncol. 2018 May 16;8:116. doi: 10.3389/fonc.2018.00116. eCollection 2018.

46.

Cancer care in regional Australia from the health professional's perspective.

Crawford-Williams F, Goodwin B, March S, Ireland MJ, Hyde MK, Chambers SK, Aitken JF, Dunn J.

Support Care Cancer. 2018 Oct;26(10):3507-3515. doi: 10.1007/s00520-018-4218-x. Epub 2018 Apr 25.

PMID:
29696425
47.

Can exercise delay transition to active therapy in men with low-grade prostate cancer? A multicentre randomised controlled trial.

Galvão DA, Hayne D, Frydenberg M, Chambers SK, Taaffe DR, Spry N, Scuffham PA, Ware RS, Hart NH, Newton RU.

BMJ Open. 2018 Apr 20;8(4):e022331. doi: 10.1136/bmjopen-2018-022331.

48.

Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.

Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD.

J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27.

PMID:
29584549
49.

MSR1 repeats modulate gene expression and affect risk of breast and prostate cancer.

Rose AM, Krishan A, Chakarova CF, Moya L, Chambers SK, Hollands M, Illingworth JC, Williams SMG, McCabe HE, Shah AZ, Palmer CNA, Chakravarti A, Berg JN, Batra J, Bhattacharya SS.

Ann Oncol. 2018 May 1;29(5):1292-1303. doi: 10.1093/annonc/mdy082.

50.

Experiences of Australian men diagnosed with advanced prostate cancer: a qualitative study.

Chambers SK, Hyde MK, Laurie K, Legg M, Frydenberg M, Davis ID, Lowe A, Dunn J.

BMJ Open. 2018 Feb 17;8(2):e019917. doi: 10.1136/bmjopen-2017-019917.

Supplemental Content

Loading ...
Support Center